ProPhase Labs (PRPH) to be removed from Nasdaq listing and registration

Rhea-AI Filing Summary

ProPhase Labs, Inc. is having its common stock removed from listing and registration on the Nasdaq Stock Market LLC under Section 12(b) of the Securities Exchange Act of 1934. Nasdaq has certified that it has complied with its own rules to strike this class of securities from listing and registration, and that the issuer has complied with applicable exchange rules and regulatory requirements for voluntary withdrawal. The notification is signed on behalf of Nasdaq by a hearings advisor, confirming the exchange’s belief that it meets all requirements to file Form 25.

Positive

• None.

Negative

• ProPhase Labs, Inc. common stock is being removed from listing and registration on the Nasdaq Stock Market LLC under Section 12(b) of the Exchange Act, which can reduce market liquidity and visibility for the shares.

Insights

Equity markets & listing standards analyst

ProPhase Labs’ common stock is being removed from Nasdaq listing and registration.

The notification shows that ProPhase Labs, Inc. common stock will be removed from listing and registration on the Nasdaq Stock Market LLC under Section 12(b). Nasdaq states it has followed its own procedures to strike the security and that the issuer followed the exchange’s rules and the relevant SEC provisions for voluntary withdrawal.

Delisting and deregistration from a major exchange usually mean the shares will no longer trade on that market, which can affect liquidity and visibility. The specific reasons or future trading venue are not described in the excerpt, so the information here is limited to the fact that the Nasdaq listing and Section 12(b) registration are being terminated.

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

000-21617

Issuer:	ProPhase Labs, Inc.
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	621 Shady Retreat Road
	Kells Building
	Doylestown	PENNSYLVANIA	18901
Telephone number:					215 345-0919

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Common Stock

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2026-01-23	By	Aravind Menon		Hearings Advisor
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What action is Nasdaq taking regarding ProPhase Labs (PRPH) stock?

Nasdaq is filing a Form 25 to remove ProPhase Labs, Inc. common stock from listing and registration on the Nasdaq Stock Market LLC under Section 12(b) of the Securities Exchange Act of 1934.

Which class of ProPhase Labs (PRPH) securities is affected?

The action applies to ProPhase Labs, Inc. common stock, which is being struck from listing and registration on the Nasdaq Stock Market LLC.

Is the removal of ProPhase Labs (PRPH) from Nasdaq described as voluntary?

The document states that the issuer has complied with the exchange’s rules and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing and registration.

Who signed the Nasdaq notification for ProPhase Labs (PRPH)?

The notification is signed on behalf of Nasdaq Stock Market LLC by Aravind Menon, identified as a Hearings Advisor.

What legal basis is cited for delisting ProPhase Labs (PRPH) stock?

The notification references Section 12(b) of the Securities Exchange Act of 1934 and 17 CFR 240.12d2-2, indicating compliance with SEC rules for removal of listing and registration.